Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 12;9(15):3716-3717.
doi: 10.1182/bloodadvances.2025016643.

Exorcizing the devil of factor VIII inhibitors

Paul C Moorehead  1
Affiliations
Editorial

Exorcizing the devil of factor VIII inhibitors

Paul C Moorehead. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Comment on

References

    1. Butera D, Pijning AE, Avery NG, et al. Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states. Blood Adv. 2025;9(15):3706–3715. - PMC - PubMed
    1. Fischer K, Lassila R, Peyvandi F, et al. Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 previously untreated patients from Europe and Canada. Res Pract Thromb Haemost. 2023;7(8):102265. - PMC - PubMed
    1. Schaefer RM, Tylki-Szymańska A, Hilz MJ. Enzyme replacement therapy for Fabry disease. Drugs. 2009;69(16):2179–2205. - PubMed
    1. Oldenburg J, Mahlangu JN, Kim B, et al. Emicizumab prophylaxis in Hemophilia A with inhibitors. N Engl J Med. 2017;377(9):809–818. - PubMed